Skip to main content
. Author manuscript; available in PMC: 2023 May 30.
Published in final edited form as: Early Interv Psychiatry. 2022 Jun 19;17(3):281–289. doi: 10.1111/eip.13326

TABLE 2.

Sample characteristicsa

Variable Total population (n = 129) No anxiety diagnosis (n = 62) Anxiety diagnosis (n = 67) Statistical test and sig.
Age, y (Mean, SD) 17.4 (4.1) 17.6 (4.4) 17.1 (3.7) t = 0.84, p = 0.40
Sex X2 = 0.70, p = .40
 Female, n 38 17 21
 Male, n 58 31 27
Medication, n 26 16 10 X2 = 2.37, p = .12
Race, n X2 = 4.46, p = .72
 Asian 5 1 4
 Black 9 6 3
 Latinx 16 7 9
 Middle Eastern 1 1 0
 Multiracial 5 2 3
 Native American 2 1 1
 N/A 42 19 23
 White 49 25 24
Education, y (Mean, SD) 10.3 (2.7) 10.3 (2.7) 10.2 (2.7) t = 0.17, p = 0.87
Comorbid Diagnoses, n
 Mood disorder 45 22 23 X2 = 0.05, p = .83
 Bipolar disorder 6 3 3 X2 = 0.01, p = .93
 Substance use disorder 8 6 2 X2 = 2.81, p = .42
 Obsessive compulsive disorder 9 - 9
 Post-traumatic stress disorder 3 - 3
 Panic disorder 12 - 12
 Agoraphobia 1 - 1
 Social anxiety 12 - 12
 Specific anxiety 16 - 16
 General anxiety 30 - 30
 Somatoform disorder 5 - 5
Treatment, n X2 = .65, p = .42
 Family focused treatment group 66 34 32
 Enhanced care treatment group 63 28 35
a

Anxiety and no anxiety groups did not differ by descriptives.